Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00905918 · ClinicalTrials.gov registry record · Phase 1
Vitamin E Supplements in Treating Patients Undergoing Surgery for Colorectal Cancer
A Phase 1 study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
NCT00905918 is a Phase 1 study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 14 participants.
The verdict
NCT00905918, a Phase 1 study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
RATIONALE: Vitamin E may help prevent the development of cancer. Studying samples of tissue from patients with colorectal cancer who receive Vitamin E before undergoing surgery in the laboratory may help doctors learn more about how Vitamin E changes biomarkers related to colorectal cancer. PURPOSE: This randomized early phase I trial is studying giving vitamin E supplements to see how it affects biomarkers in patients undergoing surgery for colorectal cancer.
Interventions
- OTHER laboratory biomarker analysis
- DIETARY_SUPPLEMENT vitamin E
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2009-06 |
| Est. Completion | 2014-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00905918
The ClinicalTrials.gov registry entry for NCT00905918 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which laboratory biomarker analysis is the first listed.
NCT00905918 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00905918 about?
NCT00905918 is a clinical study titled "Vitamin E Supplements in Treating Patients Undergoing Surgery for Colorectal Cancer". RATIONALE: Vitamin E may help prevent the development of cancer. Studying samples of tissue from patients with colorectal cancer who receive Vitamin E before undergoing surgery in the laboratory may help doctors learn more about how Vitamin E changes biomarkers related to colorectal cancer. PURPOSE...
What is the current status of trial NCT00905918?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2009-06. Estimated completion is 2014-05.
What interventions are being tested in trial NCT00905918?
The interventions under investigation include: laboratory biomarker analysis (OTHER), vitamin E (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00905918?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.